RUSH2A

• Research type

  Research Study

• Full title

  Rate of Progression in USH2A Related Retinal Degeneration (RUSH2A).

• IRAS ID

  231161

• Contact name

  Michel Michaelides

• Contact email

  Michel.Michaelides@moorfields.nhs.uk

• Sponsor organisation

  Jaeb Center for Health Research

• Clinicaltrials.gov Identifier

  NCT03146078

• Duration of Study in the UK

  4 years, 6 months, 1 days

• Research summary

  The purpose of this study is to
  • Collect information about people who have retinal degeneration caused by mutations in the USH2A gene of their DNA
  • Learn about the traits of these people
  • Study what happens to their eyes and their vision over time

  We hope to use this information to design studies for future treatments of people with USH2A related retinal degeneration.

  To take part in this study, you must be or have the following:

  • Retinal degeneration caused by mutations in the USH2A gene of your DNA
  • Be willing and able to complete/sign a consent form
  • Be able to return for all study visits over four years
  • Be at least eight years old
  • Have eyes in which photographic imaging is possible
  • Be able to do the tests for the study

  The study is taking place at about 20 different medical locations throughout the United States and other countries.

  The study will last for 4 years.

• REC name

  East of England - Essex Research Ethics Committee

• REC reference

  17/EE/0455

• Date of REC Opinion

  18 Dec 2017

• REC opinion

  Further Information Favourable Opinion